SUBSCRIBE
SUBSCRIBE

Nektar Therapeutics

NEWS
Bated Breath For Inhaled Insulin
October 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Nektar to Announce Financial Results for the Second Quarter 2021 on Thursday, August 5, 2021, After Close of U.S.-Based Financial Markets
July 27, 2021
 · 
1 min read
Policy
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Apotex
July 22, 2021
 · 
6 min read
Business
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
July 19, 2021
 · 
6 min read
Biotech Bay
Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 7, 2021
 · 
1 min read
Biotech Bay
Nektar Therapeutics Announces First Publication of NKTR-358, a Novel Molecule Designed to Selectively Stimulate Expansion and Selective Function of T Regulatory Cells, in the Journal of Translational Autoimmunity
May 20, 2021
 · 
7 min read
Biotech Bay
Nektar Therapeutics Announces its First Publication of Preclinical Data Highlighting Anti-Tumor Properties of IL-15 Agonist, NKTR-255, in the Journal for ImmunoTherapy of Cancer (JITC)
May 18, 2021
 · 
7 min read
Business
Nektar Therapeutics Reports First Quarter 2021 Financial Results
May 6, 2021
 · 
12 min read
Business
Nektar to Announce Financial Results for the First Quarter 2021 on Thursday, May 6, 2021, After Close of U.S.-Based Financial Markets
April 27, 2021
 · 
1 min read
Business
Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results
February 25, 2021
 · 
17 min read
Business
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets
February 18, 2021
 · 
1 min read
Load More